About PRISME Forum

A trusted peer network for the technology decisions shaping biopharma R&D.

Private, pre-competitive exchange among senior digital, data and technology leaders.

Why PRISME exists

R&D technology leaders face many of the same strategic and operating questions, but usually address them inside separate companies.

PRISME Forum creates a trusted setting in which they can compare approaches, challenge assumptions and learn directly from peers facing similar decisions.

Senior people. Real operating questions. No sales pitch.

What makes PRISME Forum different

Peer-led

Members surface the questions that matter. The Forum's agenda follows the priorities they are confronting, not a commercial program.

Senior peers

Participation centers on experienced leaders responsible for digital, data, technology and related capabilities across biopharma R&D.

Designed for practical use

Discussions focus on operating experience, emerging practices and decisions members can take back into their organizations.

How trust is protected

PRISME Forum is designed for pre-competitive exchange within clear antitrust and confidentiality boundaries. Members discuss shared challenges, emerging practices, technologies and operating experience. Company-confidential information, commercially sensitive matters and subjects that could restrict or distort competition remain outside the scope of Forum activity.

The Forum maintains this environment through established participation guidelines, antitrust reminders and confidentiality expectations.

  • Pre-competitive subjects
  • Clear antitrust boundaries
  • Member confidentiality
  • No sales pitches or commercial programming
  • No publication of company-attributed information without authorization

From meetings to year-round intelligence

PRISME Forum combines two annual gatherings with benchmarking, targeted surveys, Ask PRISME, Field Notes and year-round member exchange.

Together, these channels carry member questions from discussion to comparison, shared intelligence and practical action.

Explore meetings → Explore member intelligence →

Our history

PRISME Forum was formed in 2011 through the combination of PRISM and PRIME, two established communities serving pharmaceutical R&D information and technology leaders.

Since then, the Forum has evolved alongside the field itself, from traditional R&D IT and information management to the broader digital, data, AI and technology challenges shaping biopharma R&D today.

Current leadership

PRISME Forum is guided by a board of senior leaders from across the member community and supported by its executive director and secretariat.

Chair
Mike Sullivan, MBA
Bristol Myers Squibb
Senior advisor to the board
Amrik Mahal, PhD, BEM
Amino Data
Executive director
Martin Erkens, PhD

Board of directors

Dan Chapman, PhD
UCB
Lars Greiffenberg, PhD
AbbVie
Leah O'Brien
Sanofi
Anthony Rowe, PhD
GSK
Errol Sandler, PhD
PRISME Forum
Miguel Teodoro, PhD, MS
Boehringer Ingelheim

Bring your questions to the table

Membership is selective and based on the individual's role, responsibilities and fit with the Forum's scope. Prospective members may be invited to experience a meeting as a guest before a membership decision.